Deliverable: Transcripts and Summary

Objectives: Evaluate the market potential for Conceptus’ Essure, an alternative to tubal ligation

Specifically test:

• Physician perception of product
• Assess facilitators and barriers:
• Less invasive procedure:  infection risk, no general anesthesia, quicker return to daily activities
• Favorable reimbursement
• Training on procedure and use of hysteroscope – Accreditation and Certification programs
• Patient perspective: need for follow up HSG, delay in efficacy
• Competition on the horizon

Products Highlighted:

• Essure (Conceptus)
  

Topics:

• Permanent birth control options and practice patterns
• Perception and use of Essure
• Facilitators and barriers to use
• Competitive landscape
• Trends in use of Essure

Quotes:

• "This has not been a major problem for me although I know it has been a big problem for many people.”
• “As patients become more familiar with this product, there will be more of a demand for the Essure procedure. Thus more physicians will undergo training. I expect a xx% change.”
• “The important issues in a permanent sterility procedure or device are …”
• “I completed the training. I did three procedures, but…”

Screening Criteria:

• 9 obstetrician/gynecologists from high volume practices
• Mix of Essure users/ nonusers
• Treating high volume of patients with tubal ligation and/or Essure
  

Representative Institutions:

• Samaritan Medical Center
• Jackson County Memorial Hospital
• Montefiore Hospital
• Boston Medical Center
• Ocean Womens Healthcare Group
• St. Alexius Hospital
• Geauga Regional Hospital
• Lutheran General Hospital
• Piedmond Medical Center